Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-10-058331
Filing Date
2010-12-03
Accepted
2010-12-03 16:00:25
Documents
1
Period of Report
2010-12-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3765
  Complete submission text file 0001209191-10-058331.txt   5402
Mailing Address
Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300
ACORDA THERAPEUTICS INC (Issuer) CIK: 0001008848 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ACORDA THERAPEUTICS 15 SKYLINE DRIVE HAWTHORNE NY 10532
Business Address
Sabella Lauren M (Reporting) CIK: 0001360928 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50513 | Film No.: 101231526